Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Cancer|June 15, 1991
Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group BF Richards, D J Perry, M Goutsou, et al.British Journal of Cancer|June 3, 2015
Survival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxelC J Langer, V Hirsh, I Okamoto, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 12, 2013
Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancerM A Socinski, I Okamoto, J K Hon, et al.Current Oncology (Toronto, Ont.)|May 3, 2019
A network approach to developing immuno-oncology combinations in CanadaV Higenell, R Fajzel, G Batist, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group BA P Chahinian, K J Propert, J H Ware, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2012
Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancerM A Socinski, C J Langer, I Okamoto, et al.Current Oncology (Toronto, Ont.)|September 25, 2019
Crizotinib inhibition of ROS1-positive tumours in advanced non-small-cell lung cancer: a Canadian perspectiveD G Bebb, J Agulnik, R Albadine, et al.Current Oncology (Toronto, Ont.)|March 12, 2019
Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancerS A Laurie, S Banerji, N Blais, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung TumorsJ von Pawel, R von Roemeling, U Gatzemeier, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2015
A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)S Ramalingam, G Goss, R Rosell, et al.Pageof 7